Connect with us

Government

Recession resilient shares – 3 stocks that look well placed to weather the storm better than most and could even thrive

Recessions are tough, that’s the reality. But amidst the doom and gloom there is always nuance, even if sensationalist headlines might have…
The post…

Published

on

Recessions are tough, that’s the reality. But amidst the doom and gloom there is always nuance, even if sensationalist headlines might have you believe otherwise. The global economy may slow for a while but the wheel will keep turning. And not all spending is ever impacted equally. Consumers and businesses may tighten their belts and reassess their priorities, picking and choosing their battles. But they won’t stop spending entirely.

While spending on some things might be completely paused and reduced for others, it will also increase for other goods and services. Cheaper alternatives to big brand consumer products could see their sales rise as buyers look for ways to reduce their groceries spend without reducing general consumption.

Things might be purchased that wouldn’t in an effort to save money. For example, someone might buy a wrench and try to do some DIY plumbing informed by YouTube explainer videos rather than call out a plumber. The plumbing company would have lost out but the wrench retailer has a sale they wouldn’t have if economic sentiment and conditions were better.

A company might decide not to push back hiring the software developers they were planning to until the storm clouds pass. But they could instead turn to an IT outsourcing company providing cheaper remote alternatives in an emerging economy for work they feel can’t be put off. That might mean a UK-based software developer doesn’t get the pay rise they would have for moving jobs but the IT outsourcer has a contract it wouldn’t have a few months earlier.

That is of course a very simplified picture. The economy is tightly interconnected and less money spent overall, even if it is moved around to the benefit of some companies, can quickly become a vicious circle. But it does hopefully illustrate that in almost every scenario there are financial winners and losers. In a recession, the number of winners compared to losers simply drops.

As a stock picker, that makes the job of making sure a portfolio has more winners than losers harder. But not impossible. These stocks all present good cases for why they may well prove resilient over the recession we have now entered.

Kraft Heinz – some trade-down risk but demonstrating strong pricing power

I mentioned in the intro that consumer belt tightening during an economic down period can mean a switch from brand consumer products to cheaper alternatives like supermarket own brands. However, not all consumer brands are as vulnerable as others. Kraft Heinz is one whose products seem to fall into the sweet spot of still being budget friendly enough to not only survive the shopping lift cut but allow for inflation-beating raise prices. That’s reflected by the fact its valuation is actually up over 5% this year.

Like London-listed Unilever, Kraft Heinz’s recent trading updates have indicated enough of its products have shown pricing power that is strong enough to withstand increases for end consumers. Demand has dipped but higher prices, up 15.4%, have more than compensated.

Kraft-Heinz’s most recent quarterly results showed 2.9% growth in net sales to $6.5 billion despite costly divestitures (6.4% impact) and currency headwinds (reducing net sales by 2.3%) despite sales volumes being down 3.8%.

If Kraft-Heinz successfully maintains pricing power and manages trade-down risks and supply issues, it should be in a good position to justify Goldman Sachs’s recent upgrade on the stock from neutral to buy. The investment bank’s analysts have a 12-month price target of $43 for the Heinz share price compared to its current level of $37.99.

That’s over 13% upside, which would be a phenomenal result set against what is expected to be tough market conditions over the next 12 months. For UK investors, Kraft-Heinz also offers exposure to a dollar-denominated stock and the potential for further uplift from currency movements if the dollar continues to strengthen against the pound, as the consensus expects it to.

Gilead Sciences – the strength of its HIV and oncology treatments business should hold up through a recession

gilead sciences inc

Nasdaq-listed healthcare company Gilead Sciences is another stock that would see UK-based investors benefit from continued dollar strength and also has the kind of revenue streams that should prove resilient through a recession. Health, especially the treatment of life-threatening diseases, is not something that is usually cut back on and Gilead benefits from both current blockbuster drugs in the treatment of HIV and cancers and a strong-looking pipeline.

In its latest quarterly results, Gilead showed it is gradually replacing the loss of income that has resulted in a sharp drop in sales of its Remdesivir drug used to treat Covid-19. The crown jewel of its HIV/AIDs business is its Biktarvy treatment which has generated over $10 billion in sales to date and continues to grow quickly, with revenues up 22% year-on-year over the third quarter. Another HIV/AIDs treatment, Descovy, also showed 16% growth over the quarter.

In oncology, sales of Gilead’s Trodelvy treatment increased 78% in the third quarter after receiving European approval late last year. 13 non-U.S. countries are now covering the cost of the drug for patients and the company recently heralded “really strong launches” in France and Germany.

Gilead is in a strong financial position and returned $1.1 billion to shareholders in the last quarter with $928 million of that distributed as a dividend that pushed the yield to 3.7% and $180 million used for share buybacks. It also paid off $1 billion of debt early taking leveraging back to the levels it was at before the $21 billion acquisition of Trodelvy-maker Immunomedics.

Analysts at Piper Sandler and Truist Securities both recently upgraded the stock to respective overweight and buy ratings with price targets of $96 and $91, representing expected upsides of almost 21% and 14.5%.

Bunzl – a boring British business that ticks a lot of boxes

bunzl plc

Bunzl is an incredibly boring business that sells a hotchpotch of the kind of things every business needs but nobody every thinks about from napkins to disposable coffee stirrers and cleaning products. It’s not sexy and the margins are tighter than a parent of 4 at an amusement arcade the week before the first post-Christmas salary hits the bank. But therein lies Bunzl’s secret.

The tight margins of this hugely efficient, large-scale niche wholesaler have meant it has never faced any really serious competition. The upfront capital and effort that would be required for anyone to seriously take Bunzl on for market share has always put potential competitors off.

And Bunzl’s scale gives it negotiating power with its own suppliers any new market entrant would struggle to match. The fact that even Amazon has never shown any real interest in taking Bunzl on is telling. It’s the kind of business the U.S. giant would normally be expected to cast covetous glances at but has shown no sign of interest in.

Bunzl’s growth over the years owes a lot of its successful integration of smaller companies it has acquired and it currently has £1 billion in cash on its balance sheet which could be deployed for a buying spree during the tough months ahead. Analysts still see plenty of room for growth in Bunzl and there doesn’t appear to be any serious competition to the company’s dominant market position on the horizon.

The upper range of 3500 pence set as the 12-month share price target by analysts polled by the Financial Times would represent over 20% upside. Even if the mid-point consensus of 2880p would see Bunzl’s valuation remain relatively flat, there is a 3.76% dividend yield at the current share price and not losing valuation will be better than most companies manage over the year ahead.

If Bunzl does put its £1 billion cash reserve to work as expected, it should also be in a strong position to benefit from the post-recession economic bounceback.

The post Recession resilient shares – 3 stocks that look well placed to weather the storm better than most and could even thrive first appeared on Trading and Investment News.

Read More

Continue Reading

Government

“We Are Headed For Another Train Wreck”: Bill Ackman Blames Janet Yellen For Restarting The Bank Run

"We Are Headed For Another Train Wreck": Bill Ackman Blames Janet Yellen For Restarting The Bank Run

Yesterday morning we joked that every…

Published

on

"We Are Headed For Another Train Wreck": Bill Ackman Blames Janet Yellen For Restarting The Bank Run

Yesterday morning we joked that every time Janet Yellen opens her mouth, stocks dump.

Well, it wasn't a joke, and as we repeatedly noted today, while Jerome Powell was busting his ass to prevent a violent market reaction - in either direction - to his "most important Fed decision and presser of 2023", the Treasury Secretary, with all the grace of a senile 76-year-old elephant in a China market, uttered the phrase...

  • YELLEN: NOT CONSIDERING BROAD INCREASE IN DEPOSIT INSURANCE

... and the rest was silence... or rather selling.

Commenting on our chart, Bloomberg's Mark Cudmore noted it was Yellen who was "to blame for the stock slump", pointing out that "the pessimistic turn in US stocks began within a minute of Janet Yellen starting to speak."

The S&P 500 rose almost 1% in the first 47 minutes after the Fed decision. Powell wasn’t the problem either: the index was 0.6% higher in the first 17 minutes after his press conference started.

Why am I picking that exact timing of 2:47pm NY time? Because that is the minute Yellen started speaking at the Senate panel hearing. The high for the S&P 500 was 2:48pm NY time and it fell more than 2.5% over the subsequent 72 minutes. Good effort.

Picking up on this, Bloomberg's Mark Cranfield writes that banking stocks globally are set to underperform for longer after Janet Yellen pushed back against giving deposit insurance without working with lawmakers. He adds that "to an aggressive trader this sounds like an invitation to keep shorting bank stocks -- at least until the tone changes into broader support and is less focused on specific bank situations." Earlier, we addressed that too:

Looking ahead, Cranfield warns that US financials are likely to be the most vulnerable as they are the epicenter of the debate. Although European or Asian banking names may outperform US peers, that won’t be much consolation for investors as most financial sector indexes may be on a downward path.

The KBW bank index has tumbled from its highs seen in early February, but still has a way to go before it reaches the pandemic-nadir in 2020. Traders smell an opening for a big trade and that will fuel more downside. Probably until Yellen blinks.

And if Bill Ackman is right, she will be doing a whole lot of blinking in days if not hours.

Ackman crying in public

While we generally make fun of Ackman's self-serving hot takes on twitter, today he was right when he accused Yellen of effectively restarting the small bank depositor run which according to JPMorgan has already seen $1.1 trillion in assets withdrawn from "vulnerable" banks. This is what Ackman tweeted:

Yesterday, @SecYellen  made reassuring comments that led the market and depositors to believe that all deposits were now implicitly guaranteed. That coupled with a leak suggesting that @USTreasury, @FDICgov and @SecYellen  were looking for a way to guarantee all deposits reassured the banking sector and depositors.

This afternoon, @SecYellen walked back yesterday’s implicit support for small banks and depositors, while making it explicit that systemwide deposit guarantees were not being considered.

We have gone from implicit support for depositors to @SecYellen explicit statement today that no guarantee is being considered with rates now being raised to 5%. 5% is a threshold that makes bank deposits that much less attractive. I would be surprised if deposit outflows don’t accelerate effective immediately.

Ackman concluded by repeating his ask: a comprehensive deposit guarantee on America's $18 trillion in assets...

A temporary systemwide deposit guarantee is needed to stop the bleeding. The longer the uncertainty continues, the more permanent the damage is to the smaller banks, and the more difficult it will be to bring their customers back.

... but as we noted previously pointing out, you know, the math...

... absent bipartisan Congressional intervention - which is very much unlikely until the bank crisis gets much, much worse - this won't happen and instead the Fed will continue putting out bank fire after bank fire - even as it keeps hiking to overcompensate for its "transitory inflation" idiocy from 2021, until the entire system burns down, something which Ackman's follow-up tweet was also right about:

Consider recent events impact on the long-term cost of equity capital for non-systemically important banks where you can wake up one day as a shareholder or bondholder and your investment instantly goes to zero. When combined with the higher cost of debt and deposits due to rising rates, consider what the impact will be on lending rates and our economy.

The longer this banking crisis is allowed to continue, the greater the damage to smaller banks and their ability to access low-cost capital.

Trust and confidence are earned over many years, but can be wiped out in a few days. I fear we are heading for another a train wreck. Hopefully, our regulators will get this right.

Narrator: no, they won't.

Tyler Durden Wed, 03/22/2023 - 21:20

Read More

Continue Reading

International

China’s Auto Industry Association Urges “Cooling” Of Price War, As Major Manufacturers Slash Prices

China’s Auto Industry Association Urges "Cooling" Of Price War, As Major Manufacturers Slash Prices

Just hours after we wrote about maniacal…

Published

on

China's Auto Industry Association Urges "Cooling" Of Price War, As Major Manufacturers Slash Prices

Just hours after we wrote about maniacal price cutting in the automotive industry in China, China's auto industry association is urging automakers to "cool" the hype behind price cuts.

The statement was made in order to "ensure the stable development of the industry", Automotive News Europe reported on Tuesday. 

The China Association of Automobile Manufacturers even went so far as to put out a message on its official WeChat account, stating that "A price war is not a long-term solution". Instead "automakers should work harder on technology and branding," it said. 

The consumer disagrees...

Recall we wrote earlier this week that most major automakers were slashing prices in China. The move is coming after lifting pandemic controls failed to spur significant demand in China, the Wall Street Journal reported this week. Ford and GM will be joined by BMW and Volkswagen in offering the discounts and promotions on EVs, the report says. 

Retail auto sales plunged the first two months of the year and automakers are facing additional challenges in trying to transition their business models to prioritize EVs over conventional internal combustion engine vehicles. 

Ford is offering $6,000 off its Mustang Mach-E, putting the standard version of its EV at just $31,000. Last month, only 84 of the vehicles were sold, compared to 1,500 sales in December. There was some pulling forward of demand due to the phasing out of subsidies heading into the new year, and Ford had also cut prices by about 9% in December. 

A spokesperson for Ford called it a "stock clearance". 

Discounts at Volkswagen are ranging from around $2,200 to $7,300 a car. The cuts will affect 20 gas powered and electric models. Its electric ID series is seeing price cuts of almost $6,000. The company called the cuts "temporary promotions due to general reluctance among car buyers, the new emissions rule and discounts offered by competitors."

Even more shocking is Citroën-maker Dongfeng Motor Group, who is offering a 40% discount on its C6 gas-powered sedan, now priced at $18,000. 

Kelvin Lau, an analyst at Daiwa Capital Markets, told the Journal that automakers are also trying to get rid of 500,000 vehicles collectively stored in their inventory, most of which are older vehicles that won't meet new emissions standards.

David Zhang, a Shanghai-based independent automobile analyst, added: “Some car makers have been seeing very few sales. At this rate, the manufacturers’ production and dealership networks will collapse.”

Tyler Durden Wed, 03/22/2023 - 18:00

Read More

Continue Reading

Government

How Fauci’s Wife Used NIH Position To Backstop Her Husband’s Pandemic Health Directives

How Fauci’s Wife Used NIH Position To Backstop Her Husband’s Pandemic Health Directives

Authored by Adam Andrzejewski via OpenTheBooks,

It’s…

Published

on

How Fauci's Wife Used NIH Position To Backstop Her Husband’s Pandemic Health Directives

Authored by Adam Andrzejewski via OpenTheBooks,

It's the Washington, D.C. power couple that cost taxpayers nearly $1 million per year.

While Dr. Anthony Fauci gave the nation its pandemic public policy prescriptions, his wife, Dr. Christine Grady, the Chief Bioethicist at Fauci’s employer, the National Institutes of Health (NIH) provided the moral framework.

The Faucis are important to the center-left, because they represent the pinnacle moment of the administrative state – top-down public policy run by an elite group of government scientists.

Conversely, to the center-right, the Faucis represent “the fatal conceit of the elites.” As Noble Laureate economist Friedrich Hayek theorized, the elites are no match for billions of free people acting in their own best interests.

MEET THE FAUCIS

While Tony Fauci was the top paid federal bureaucrat and out-earned the U.S. President at $480,654 per year, Christine Grady, as the chief bioethicist at NIH out-earned the U.S. Vice President ($243,749). When adding 35-percent in benefits, the couple cost taxpayers an estimated nearly $1 million per year.

CHART: Tracking the Fauci household net worth which increased from $7.6 million to $12.6 million between the start of 2020 and the end of 2021. Source: OpenTheBooks.com lawsuit production from NIH on Fauci’s financial disclosures.

It’s difficult to know where Anthony Fauci ends and Christine Grady begins. Here’s how Tony Fauci described Grady’s influence on his public policy decisions:

I've benefited greatly from this partnership of overlapping interest and common interest. So, a lot of the things that I do with regard to the development of vaccines, the development of therapies, being involved with outbreaks and pandemics, have ethical overtones to them. I can say that I am very blessed to be living with someone who is very likely, most people think, one of the most outstanding ethicists in the world. To have her in the house -- you know, as a consultant on ethical issues—is pretty advantageous.

So, the Faucis lived a conflict of interest at the breakfast table, the office, and back home around the dinner table. However, NIH has never acknowledged this.

In fact, NIH forced our organization to file two federal lawsuits with the public-interest law firm Judicial Watch as our lawyers to finally bring transparency to the Fauci/Grady job descriptions, conflict of interest documents, financial and ethics disclosures, contracts, and other documents.

Then, NIH slow-walked thousands of pages of production. Yet, no nepotism waivers were produced, no acknowledgement of conflicting interests, and no records documenting violations of federal ethics policy.

Slide developed by Dr. Anthony S. Fauci and presented by Dr. Christine Grady during her NIH presentation COVID Vaccines: Approaches to Vaccine Trial Design November 4 2020. Many of the prescriptions on this slide showed little efficacy in after-action studies. Source: FOIA

While Grady’s work during the pandemic was described as “invaluable” by then-NIH director Francis Collins, the general public knows little about her day-to-day responsibilities. 

An open records request for Grady’s job description reveals she, too, is meant to use her position to influence policy.

Screenshot from Christine Grady’s job description, received. Source: FOIA

Advocating Lockdowns

Dr. Fauci knew that his “draconian policies” on social isolation and economic lockdowns would have “collateral negative consequences,” and admitted Christine Grady was a driving force behind his hardline approach.

In a November 2021 interview with the couple, Fauci said that he gained strength from his wife’s support saying, “background and her experience in really core ethical principles [helped] me to really feel much more comfortable in what I was saying.”

In the interview, Christine Grady described how she mind-mapped national policy with her husband:

"But we've had conversations about the sort of consequences of telling people to stay home and what it would do for the economy. And there were a lot of people in those days that, and still who said, it's ruining the economy. It's much more important to just keep things going and not worry about transmitting virus…I said, that one of the messages should be, how many lives are you willing to sacrifice? And that message would be pretty stark and pretty brutal, but that's really what the trade-off was…And so we've had that kind of conversation over dinner more than once, actually.”

Fauci replied that these conversations “sharpened [his] resolve” to move forward with lockdown policies.

Social isolation was one of the individual sacrifices Grady and Fauci thought were necessary to make on behalf of “public health.”

Vaccine Development & Public Safety

Like her husband, Grady exclusively focused her attention and remarks on vaccine development rather than other potential ways to treat and combat the spread of COVID-19.

One major paper she co-authored in 2020 advocated for vaccines to be distributed under emergency use authorization (EUA), which is how the federal government ultimately proceeded.

In this paper, Grady’s advocacy for vaccines came with a troubling acknowledgement:

 “even with mandated safety monitoring after EUA distribution, it would be difficult or impossible to ascertain vaccine-induced adverse events.”

However, during most of her public presentations, she asserted that vaccines were developed in a fast, but “safe and rigorous” manner. Just one of many examples can be found here.

By November 2021, she said the risk of unknown long-term effects were “not zero” but that “there is a balance between benefiting the public health now versus waiting for all the information we might get.”

Despite these admissions, Grady often said she was “disturbed” by vaccine hesitancy, implying that safety concerns were somehow unreasonable.

Vaccine Mandates

Grady’s stance on vaccine mandates changed radically throughout the pandemic.

In June 2020, a presentation she gave suggested “immunity passports” could cause “discrimination without much overall gain.” A passport system would allow businesses to limit or deny access to those who remained unvaccinated.

Six months later, in January 2021, Grady said, “I do believe that healthcare providers, like everyone else, should have the choice” whether to take the vaccine or not.

But by early October 2021, Grady had decided the choice facing health care workers was a drastically different one: whether to get the vaccine or lose their jobs.

Later that month, she also flipped her position on vaccine passports. What once was a potential source of discrimination was recast as a way to access “social benefits” like restaurants and movie theaters.

It’s a disturbing way to describe Americans free association of movement.   

Grady went on to co-author a March 2022 report approving of social ostracization for the vaccine-hesitant and encouraging employers to pressure their workers:

“While some employers might understandably feel hesitant to pressure employees to get vaccinated, our analysis suggests that it is often ethically acceptable to inform, encourage, strongly encourage, incentivize, and subtly pressure unvaccinated people to benefit them, the organization, and other employees.”

In fewer than two years, Grady had completely altered her assessment of vaccine mandates and widespread restrictions on the behavior of unvaccinated Americans. Gone were concerns about discrimination and freedom of choice.

As Dr. Fauci pushed and pressured the public to get vaccinated for the sake of their neighbors and family members, Grady began considering it ethical to fire workers who did not comply.

Likewise, it became a “social benefit” to get a vaccine passport that would allow people to avoid government restrictions on their free movements.

Screenshot of Tweet – Dr. Fauci and Dr. Grady maskless at the Washington National baseball game in summer 2020 after Fauci threw out the first pitch.

Mask Mandates

While her husband advocated masking and double masking—even when “fully vaccinated”—Dr. Grady consistently backed his position.

In July 2020, during an InStyle interview, Grady answered questions about masking:

Interviewer: Let me ask you, Chris, as a bioethicist, what do you make of this moment we're in, when even a mask has become more of a divisive issue?

Grady: Well, I would say that masks shouldn't be divisive. It's a relatively easy way to protect one's self and others. And so for public health reasons, I think everybody should do it. From an ethical perspective there is always this tension between what you ask people to do that feels like a restriction of their liberty and what is required for public health. And in this case, it seems like a slam dunk. It's not restricting liberty much, and it's very helpful for public health.

Grady was consistent and in November 2021 spoke to the ethical balancing test of public safety versus individual freedom and never viewed mask wearing to be much of an infringement on individual rights:

“There's a classic tension between public health, and individual interests and freedoms. Where there seems to be this conflict to the things that we do to protect the public health, and to protect the population for the common good. Sometimes they are perceived to be, and sometimes they do in small ways, infringe on people's freedoms. There are principles of public health ethics that help you sort out the kinds of interventions that we should use: Things that are effective, that are proportional, where the benefits outweigh the risks that are necessary, that are least infringement possible, that are transparent, that we can publicly justify.

…What's striking to me is that, the kinds of burdens that we've asked people to undertake, like putting on a mask, don't really infringe on one's freedoms very much. They're low burden and they have an effect. They do protect the person who's wearing the mask, as well as the people that are around them.”

A recent credible study on mask wearing during the pandemic argued there is no clear impact of masking on Covid-19 infection rates.

Patients Dying in Isolation

During the pandemic, Grady revealed a default preference for government control over individual rights and responsibilities. Grady was an early proponent of one of the most heinous pandemic polices: patients dying in isolation.

For example, while uncritically accepting dying in isolation as a fact of the pandemic, Grady’s primary solution was to expand funding for health care workers to have access to therapy and other resources to heal from their “moral distress.”

As early as April 2020 Grady said:  

“Because of visiting policies and fear of contagion sometimes when somebody is really sick their family cannot visit them, they can't see them…the stress and the sadness and the isolation on families is and is going to be great.” 

In a November 2020 NIH presentation she called these “lonely” deaths “understandable:”  

"It’s a lonely kind of death, many institutions, understandably have visitor policies which either restrict the number of visitors to one or zero so sometimes people are dying without having their family nearby and that puts an additional burden on the healthcare staff.” 

In one co-authored paper urging healthcare workers to “temper these potentially dehumanizing scenarios with imaginative solutions that do not sacrifice compassion and equal respect on the altars of safety and efficiency.” 

She interrogates the tension between individual freedom and community safety in a book published April 26, 2022, as a co-author proposing a radical “solidarity model” for ethics in healthcare, stating that rather than emphasizing a respect for individuals to make decisions in their own interest:  

“We should recognize that there are times when solidarity takes precedence over individual liberties, and broadening our concept of “respect for persons” means uniting as a profession to protect all those who expect to receive care from nurses in whatever healthcare setting they find themselves.” 

She co-edited a section in the same book arguing this extends to dying in insolation: 

“The solidarity model may apply to restricted family visitation, which generated moral distress for nurses, particularly when patients died without loved ones present…”

CONCLUSION – GRADY AND THE NEXT PANDEMIC

As demonstrated by her own words, Grady’s record evinces an understanding of ethics that begs fundamental moral questions, regularly subordinates individuals beneath an amorphous “public health,” and relies on subtle but unacknowledged shifts to retain an alleged moral high ground.

While some of her observations early in the pandemic did show an interest in providing nuance to policymaking—questioning the usefulness of immunity passports and highlighting issues with long-term vaccine effects under a EUA rollout—this quickly gave way to conformity to broader political zeitgeist, painting pushback as ignorant, uncaring, and simply wrong.

By 2021 her public statements never suggested a limit to sacrifices the individual should ethically make on behalf of “public health,” from masking, to taking vaccines, to foregoing family gatherings even at the point of one’s own death.

Both Fauci and Grady made clear that they wish for ethicists like Grady to have more power and more influence over political decision-making.

As Grady remains the chief NIH bioethicist, Americans should ponder: does Grady’s philosophy advance what is “fair” and “just” in public health policy? What does her continued leadership mean for the future of American policy.

Taxpayers compensate Grady generously, and they’re owed full transparency about her role, responsibilities and influence – during the pandemic and into the future.

Note: We reached out to Dr. Christine Grady and NIH for comment. While acknowledging our requests, no statement or comment was received before publication.

ADDITIONAL READING

Dr. Anthony Fauci: The Highest Paid Employee In The Entire U.S. Federal Government Published January 21, 2021 | Forbes

Dr. Anthony Fauci’s Little Known Biodefense Work. It’s How He Became The Highest Paid Federal Employee. Published October 20, 2021 | Forbes

No, Fauci’s Records Aren’t Available. Why Won’t NIH Immediately Release Them? Published January 12, 2022 | Forbes

Breaking: Fauci’s Net Worth Soared To $12.6 Million During The Pandemic – Up $5 Million (2019-2021). Published September 28, 2022 | OpenTheBooks.Substack.com

HISTORIC RELEASE: Dr. Anthony Fauci’s Official Work Calendar (November 2019 – March 2020) | Published October 20, 2022 | OpenTheBooks.Substack.com

ABOUT US

OpenTheBooks.com – We believe transparency is transformational. Using forensic auditing and open records, we hold government accountable.

In the years 2021 and 2022, we filed 100,000+ FOIA requests and successfully captured $19 trillion government expenditures: nearly all federal spending; 50 state checkbooks; and 25 million public employee salary and pension records from 50,000 public bodies across America.

Our works have been featured at the BBC, Good Morning America, ABC World News Tonight, The Wall Street Journal, USA Today, C-SPAN, Chicago Tribune, The New York Times, NBC News, FOX News, Forbes, National Public Radio (NPR), Sinclair Broadcast Group, & many others.

Our organization accepts no government funding and was founded by CEO Adam Andrzejewski. Our federal oversight work was cited twice in the President's Budget To Congress FY2021. Andrzejewski's presentation, The Depth of the Swamp, at the Hillsdale College National Leadership Seminar 2020 in Naples, Florida posted on YouTube received 3.8+ million views.

Tyler Durden Wed, 03/22/2023 - 21:00

Read More

Continue Reading

Trending